Table 5 Cohort B: summary of study characteristics
Characteristics | Number | (%) | |
|---|---|---|---|
n = 43 | |||
Funding | |||
Not for profit | 10 | (23.3) | |
For profit | 11 | (25.6) | |
Mixed (not for profit and for profit) | 2 | (4.7) | |
Not reported | 20 | (45.6) | |
Unclear | 0 | (0.0) | |
Type of Wound | |||
Leg ulcer | 24 | (55.8) | |
Diabetic foot ulcer | 13 | (30.2) | |
Pressure ulcer | 5 | (11.6) | |
Mixed ulcers | 1 | (2.3) | |
Intervention | |||
Device | 28 | (65.1) | |
Drug | 12 | (27.9) | |
Surgery | 1 | (2.3) | |
Care management | 2 | (4.7) | |
Comparator (note, in trials >2 arms there is >1 comparator) | n = 51 | ||
Placebo | 19 | (37.3) | |
Usual care | 8 | (15.7) | |
Device | 17 | (33.3) | |
Drug | 4 | (7.8) | |
Surgery | 2 | (3.9) | |
Care management | 1 | (2.0) | |
Duration of follow up | Median | (IQR) | Range |
Weeks | 8 | (4–13) | 2–104 |